Unbound MEDLINE

Limited effect of thoracoscopic splanchnicectomy in the treatment of severe chronic pancreatitis pain: a prospective long-term analysis of 75 cases. Surgery [Surgery] Journal article

 
TitleLimited effect of thoracoscopic splanchnicectomy in the treatment of severe chronic pancreatitis pain: a prospective long-term analysis of 75 cases.
Author(s)Buscher HC, Schipper EE, Wilder-Smith OH, Jansen JB, van Goor H 
InstitutionDepartment of Surgery, Anesthesiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
SourceSurgery 2008 Jun; 143(6):715-22.
MeSHAdolescent
Adult
Aged
Analgesics, Opioid
Female
Follow-Up Studies
Humans
Kaplan-Meiers Estimate
Longitudinal Studies
Male
Middle Aged
Pain
Pain Measurement
Pancreatitis, Chronic
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Severity of Illness Index
Splanchnic Nerves
Thoracoscopy
Treatment Outcome
AbstractBACKGROUND: Bilateral thoracoscopic splanchnicectomy is a minimally invasive method of treating pain in patients with chronic pancreatitis. It offers good, short-term pain relief, but long-term success is difficult to predict. We analyze long-term results and identify factors predicting success of splanchnicectomy.
METHODS: A total of 75 consecutive chronic pancreatitis patients underwent bilateral thoracoscopic splanchnicectomy with long term follow-up (>or=1 year). Treatment success was analyzed using the Kaplan-Meier method, and possible predictive factors (etiology, gender, onset of pancreatitis, previous pancreatitis-related surgery, opioid use, pathology at imaging, technical success, and post-splanchnicectomy complications) via the Cox proportional hazards regression model. We compared patients with long-term pain relief, patients who failed the procedure within 1 year, and those who had pain recurrence after > 1 year. Further treatments after failed splanchnicectomy were evaluated.
RESULTS: A total of 66 patients (88%) were on continuous opioids; 47 (63%) had prior pancreatitis-related interventions. Treatment was successful in 52% of patients at 12 months, 38% at 24 months, and 28% at 48 months. At the end of follow-up, 21 patients (28%) reported pain relief, of whom 13 were completely pain free without any additional treatment. Pancreatic surgery after failed splanchnicectomy relieved pain in only 13% of patients. Technical success was the only independent factor significantly associated with successful splanchnicectomy outcome (P = .03). Preoperative opioid use showed a strong tendency to be associated with unsuccessful outcome (P = .07).
CONCLUSION: Splanchnicectomy offers prolonged (>4 years) benefit in 1 of 4 patients with severe chronic pancreatitis pain. Prior opioid use may adversely impact pain relief after splanchnicectomy.
Languageeng
Pub Type(s)Journal Article
PubMed ID18549887
  
Advertise on this site.